CAN “AREA UNDER THE CURVE” BASED ON ABBREVIATED PHARMACOKINETICS BE USED FOR CYCLOSPORINE MICROEMULSION (NEORAL®) MONITORING IN KIDNEY TRANSPLANT RECEPIENTS?